263700 — Carelabs Co Share Price
Last trade - 00:00- KR₩69bn
- KR₩28bn
- KR₩83bn
- 69
- 60
- 83
- 84
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.93 | ||
| Price to Tang. Book | 1.12 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.82 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -12.24% | ||
| Return on Equity | 7.79% | ||
| Operating Margin | -12.18% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 76,666.4 | 93,933.96 | 87,607.19 | 81,827.46 | 83,187.39 | n/a | n/a | 4.02% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +299.96 | -68 | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Carelabs Co Ltd is a Korea-based company engaged in provision of platform services including mobile healthcare and beauty care. The Company operates its business through four segments. The Platform Business segment operates healthcare platforms, beauty care platforms and medical professional recruiting platforms. The Marketing Business segment provides services such as marketing planning, production and agency. The Solution Business segment provides customer relationship management (CRM) software, prescription security systems, pharmacy billing programs and electronic medical records (EMR) solutions. The Other Business segment operates real estate leasing businesses.
Directors
- Gyeong Deuk Park CEO (36)
- Chung Hui Park OTH (41)
- Wu Yeong Cho DRC (42)
- Yeong Jung Cho DRC (39)
- Nam Jin Kim DRC (53)
- Tae Yeong Jung NID (38)
- Jin Won Kim NID (40)
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- April 10th, 2012
- Public Since
- March 28th, 2018
- No. of Shareholders
- 17,230
- No. of Employees
- 121
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 19,399,979
- Address
- 2F, 20, Banpo-daero 28-gil, Seocho-gu, SEOUL, 06252
- Web
- https://www.carelabs.co.kr/
- Phone
- +82 269292340
- Auditors
- Hanwool Accounting
Upcoming Events for 263700
Similar to 263700
Actoz Soft Co
Korea Exchange - KOSDAQ
Ahnlab
Korea Exchange - KOSDAQ
Alchera
Korea Exchange - KOSDAQ
Alticast
Korea Exchange - KOSDAQ
APS
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:47 UTC, shares in Carelabs Co are trading at KR₩3,535. This share price information is delayed by 15 minutes.
Shares in Carelabs Co last closed at KR₩3,535 and the price had moved by -1.8% over the past 365 days. In terms of relative price strength the Carelabs Co share price has underperformed the FTSE Developed Asia Pacific Index by -9.31% over the past year.
The overall consensus recommendation for Carelabs Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreCarelabs Co does not currently pay a dividend.
Carelabs Co does not currently pay a dividend.
Carelabs Co does not currently pay a dividend.
To buy shares in Carelabs Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩3,535, shares in Carelabs Co had a market capitalisation of KR₩69bn.
Here are the trading details for Carelabs Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 263700
Based on an overall assessment of its quality, value and momentum Carelabs Co is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Carelabs Co is KR₩12,000. That is 239.46% above the last closing price of KR₩3,535.
Analysts covering Carelabs Co currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Carelabs Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +16.35%.
As of the last closing price of KR₩3,535, shares in Carelabs Co were trading +27.75% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Carelabs Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩3,535.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Carelabs Co's management team is headed by:
- Gyeong Deuk Park - CEO
- Chung Hui Park - OTH
- Wu Yeong Cho - DRC
- Yeong Jung Cho - DRC
- Nam Jin Kim - DRC
- Tae Yeong Jung - NID
- Jin Won Kim - NID